JBIOJBIONASDAQ

Revenue (LTM)

Net Income (LTM)

$-127M

-83.0% YoY

Free Cash Flow

$-95M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.1B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	0	0	0	0	0
Gross Profit	-0	-0↓353.3%	-0↓41.2%	-0↓193.8%	-0↑90.8%
Operating Income	-23	-53↓131.2%	-81↓52.9%	-75↑8.4%	-114↓52.2%
Net Income	-23	-52↓124.3%	-76↓46.6%	-70↑7.8%	-127↓83.0%
EBITDA	-23	-51↓124.1%	-75↓46.6%	-69↑8.1%	-114↓63.9%
EPS Diluted	-32.96	-73.67↓123.5%	-100.38↓36.3%	-85.26↑15.1%	-4.06↑95.2%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	54	22↓58.7%	23↑4.9%	34↑43.7%	88↑162.0%
Total Current Assets	174	131↓24.6%	124↓5.5%	80↓35.5%	336↑319.6%
Total Assets	175	135↓22.8%	127↓5.8%	80↓37.0%	350↑335.4%
Total Current Liabilities	3	8↑205.2%	18↑126.6%	4↓78.3%	17↑332.1%
Total Liabilities	3	9↑190.6%	18↑109.9%	4↓78.3%	17↑342.9%
Total Equity	172	127↓26.5%	109↓13.6%	76↓30.2%	333↑335.0%
Total Debt	1	1↑89.9%	1↓38.1%	0↓38.2%	1↑73.6%
Net Debt	-54	-21↑60.3%	-23↓7.1%	-33↓46.1%	-88↓163.1%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-27	-39↓42.8%	-57↓45.1%	-71↓25.4%	-95↓33.0%
Capital Expenditure	-0	-0↓7.7%	-0↑27.2%	0	-0
Free Cash Flow	-28	-39↓42.6%	-57↓44.8%	-71↓25.1%	-95↓33.3%
Stock-Based Comp	0	0	0	0	0
Net Change in Cash	50	-32↓164.1%	1↑103.4%	10↑837.8%	-34↓429.0%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance